Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study

被引：0
|
作者：
Tiago Torres
Luis Puig
Ron Vender
Charles Lynde
Stefano Piaserico
Jose M. Carrascosa
Paolo Gisondi
Esteban Daudén
Curdin Conrad
Pedro Mendes-Bastos
Paulo Ferreira
Luiz Leite
Justin D. Lu
J. Valerio
M. Bruni
F. Messina
A. Nidegger
M. Llamas-Velasco
E. del Alcazar
A. Mufti
Kyra White
G. Caldarola
Laetitia Teixeira
Paolo Romanelli
K. Desai
Spyridon Gkalpakiotis
Marco Romanelli
Jensen Yeung
Miguel Nogueira
Andrea Chiricozzi
机构：
[1] Centro Hospitalar Universitário do Porto,Department of Dermatology
[2] Instituto de Ciências Biomédicas Abel Salazar,Department of Dermatology
[3] University of Porto,Dermatology Unit, Department of Medicine
[4] Hospital de la Santa Creu i Sant Pau,Department of Dermatology
[5] McMaster University,Section of Dermatology and Venereology, Department of Medicine
[6] Lynde Institute for Dermatology,Dermatology Department
[7] University of Padua,Department of Dermatology
[8] Germans Trias i Pujol University Hospital (HUGTP),Division of Dermatology, Department of Medicine
[9] Autonomous University of Barcelona (UAB),Center for Health Technology and Services Research (CINTESIS), Institute of Biomedical Sciences Abel Salazar
[10] University of Verona,Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery
[11] Hospital Universitario de la Princesa,Department of Dermatovenereology, Third Faculty of Medicine
[12] Instituto de Investigación Sanitaria La Princesa (IIS-IP),Department of Dermatology
[13] Lausanne University Hospital CHUV,undefined
[14] University of Lausanne,undefined
[15] Hospital CUF Descobertas,undefined
[16] Clínica Médica Belém,undefined
[17] Michael G. DeGroote School of Medicine,undefined
[18] Faculty of Medicine,undefined
[19] University of Toronto,undefined
[20] Probity Medical Research,undefined
[21] Fondazione Policlinico Universitario A. Gemelli IRCCS,undefined
[22] Università Cattolica del Sacro Cuore,undefined
[23] University of Porto (ICBAS.UP),undefined
[24] University of Miami,undefined
[25] Miller School of Medicine,undefined
[26] Charles University and Kralovske Vinohrady University Hospital,undefined
[27] University of Pisa,undefined
来源：
American Journal of Clinical Dermatology | 2021年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：567 / 579
页数：12
相关论文
共 50 条
  • [41] The relationship between TNF-α, IL-1, IL-12, IL-17, IL-23, IL-36 expression and treatment response in psoriasis histopathologically and immunohistochemically
    Temiz, Selami Aykut
    Dursun, Recep
    Findik, Siddika
    Ataseven, Arzu
    Isik, Begum
    Ozer, Ilkay
    CUTANEOUS AND OCULAR TOXICOLOGY, 2024, 43 (03) : 182 - 189
  • [42] COST PER RESPONDER OF BIMEKIZUMAB AGAINST IL17A, IL-12/23 AND IL-23 INHIBITORS IN THE TREATMENT OF PSORIATIC ARTHRITIS IN SWEDEN
    Lyris, N.
    Geale, K.
    Aldven, M.
    Engstrom, A.
    Willems, D.
    VALUE IN HEALTH, 2023, 26 (12) : S178 - S178
  • [43] IL-23 Versus IL-17 in the Pathogenesis of Psoriasis: There Is More to the Story Than IL-17A
    Armstrong, April W.
    Read, Charlotte
    Leonardi, Craig L.
    Kircik, Leon H.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2019, 18 (08) : S202 - S208
  • [44] Adverse events associated with IL-23 and IL-12/23 inhibitors in the clinical management of psoriasis: a comprehensive pharmacovigilance analysis
    Shi, Wentao
    Zhao, Ziyi
    Zhai, Yinghong
    Ye, Xiaofei
    Xu, Feng
    BMC PHARMACOLOGY & TOXICOLOGY, 2025, 26 (01):
  • [45] IL-19 is a novel component of the pathogenetic IL-23/IL-17 cascade in psoriasis
    Witte, E.
    Kokolakis, G.
    Witte, K.
    Philipp, S.
    Doecke, W.
    Babel, N.
    Wittig, B.
    Warszawska, K.
    Kurek, A.
    Erdmann-Keding, M.
    Kunz, S.
    Asadullah, K.
    Kadin, M.
    Volk, H.
    Sterry, W.
    Wolk, K.
    Sabat, R.
    EXPERIMENTAL DERMATOLOGY, 2014, 23 (03) : E20 - E20
  • [46] Interleukin (IL)-19 is a novel component of the pathogenetic IL-23/IL-17 pathway in psoriasis
    Witte, E.
    Kokolakis, G.
    Witte, K.
    Philipp, S.
    Babel, N.
    Wittig, B. M.
    Erdmann-Keding, M.
    Kadin, M. E.
    Volk, H. -D.
    Sterry, W.
    Wolk, K.
    Sabat, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E155 - E155
  • [47] Onset of Plaque Psoriasis Treatment Responses With Anti IL-17/IL-23 Biologic Therapies
    Fried, Richard G.
    Lebwohl, Mark
    Bettencourt, Miriam
    Koo, John
    Jacobson, Abby
    JOURNAL OF DRUGS IN DERMATOLOGY, 2022, 21 (08) : 854 - 860
  • [48] IL-23 is important in IL-17 induction in tuberculosis
    Khader, SA
    Pearl, J
    Gilmartin, L
    Jelly-Gibbs, DM
    Ghilardi, N
    de Sauvage, FJ
    Cooper, AM
    FASEB JOURNAL, 2004, 18 (04): : A90 - A90
  • [49] IL-23/IL-17 biology and therapeutic considerations
    Dong, Chen
    JOURNAL OF IMMUNOTOXICOLOGY, 2008, 5 (01) : 43 - 46
  • [50] The IL-23–IL-17 axis in inflammatory arthritis
    Erik Lubberts
    Nature Reviews Rheumatology, 2015, 11 : 415 - 429
12345